glp-1 and cancer Research Reveals Potential Risks of Popular Medications for Some with Neuroendocrine GLP-1 Agents vs Aspirin: A
Description
Given the considerable continued growth expected in the GLP-1 pipeline, Primes team of clinical experts actively monitors this emerging landscape
doi: 10.1210/jc.2013-3766 102 StyrkarsdottirUTraganteVStefansdottirLThorleifssonGOddssonASrensenEet al
6.6%, p -value 0.01)
Eligibility decisions are made by licensed clinicians, and approval is not assured even when all requested information is submitted
Based on this mechanism, the BJA consensus statement suggests that erythromycin may be considered as an adjunctive measure for patients at high risk of GLP-1 RArelated delayed gastric emptying
